Mar 8, 2016

Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice

Posted by in categories: biotech/medical, life extension

Further support for SENS strategy. Senolytics improve vascular biomarkers in mice. This is exactly the work my project MMTP is working on, we are looking at conducting robust lifespan studies for Senolytics including the two compounds used here.

The next step will be to test Senolytics with MSC stem cells to see if we can further improve on vascular aging and pathology such as atherosclerosis.

We are launching a fundraiser on lifespan.io in April to get this work done, please support us!

Read more

Comments are closed.